Axial Spondyloarthritis

Rob DillardRheumatology | April 27, 2023

Recently, CreakyJoints, the digital, international patient community for people with all forms of arthritis, announced a ...

Kaitlyn D’OnofrioPsoriatic Arthritis | April 10, 2023

A study retrospectively compared rates of treatment retention with golimumab among patients with rheumatoid arthritis ...

Kaitlyn D’OnofrioACR 2020 Conference | August 1, 2023

Several studies discussed during the American College of Rheumatology (ACR) 2020 Convergence talked about axial ...

Kaitlyn D’OnofrioRheumatology | October 2, 2020

Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about the ...

Kaitlyn D’OnofrioCOVID-19 | April 7, 2023

The COVID-19 pandemic does not appear to have significantly affected the disease course of patients with inflammatory ...

Kaitlyn D’OnofrioPsoriatic Arthritis | April 10, 2023

Inflammatory arthritis (IA) patients often experience fatigue; 41% to 51% of rheumatoid arthritis (RA), psoriatic ...

Kaitlyn D’OnofrioRheumatology | June 8, 2020

Eli Lilly and Company received an additional approved indication for its drug Taltz® (ixekizumab), which is now ...

Kaitlyn D’OnofrioRheumatology | April 1, 2019

The U.S. Food and Drug Administration (FDA) has granted its approval for Cimzia (certolizumab pegol), an injectable drug ...

JC LandryPsoriatic Arthritis | September 11, 2023

According to an observational cohort study, effects of switching from an originator to biosimilar etanercept depend on ...

Kaitlyn D’OnofrioRheumatology | October 31, 2018

A recent study found ixekizumab to be a safe and effective treatment for active radiographic ...